The North American Viral Hepatitis Elimination Summit, a collaboration of the American Association for the Study of the Liver (AASLD), Canadian Association for the Study of the Liver (CASL), and Mexican Association of Hepatology (AMH) will be delivered on Tuesday March 18th, 2025, at the Global Hepatitis Summit in Los Angeles.
March 18th, 2025
10AM to 5PM
Objectives:
- Bring high level attention to hepatitis elimination in North America
- Advance knowledge of strategies to reduce health disparities
- Explore novel programs that how to apply these more broadly across countries in North America
10:00am – 10:10am | Introductions and Overview |
Session 1: Taking Stock (profiles in NA): trends, progress towards targets and big scale initiatives | |
10:10am – 10:25am | Canada – Canada’s STBBI Action Plan 2024-2030 – |
10:25am – 10:40am | Mexico – Expansion of HCV management in primary care |
10:40am – 10:55am | United States — US HCV elimination plan |
11:00am – 11:15am | PANEL DISCUSSION: Includes patient representation (WHA,NVHR) |
Session 2: Diagnostics with the goal of increasing treatment | |
11:20am – 11:35am | HCV POCT and barriers to test & treat approach |
11:35am – 11:50am | HBV testing – what needs to ∆ in policies & practice (qHBsAg, HBV POCT) |
11:50am – 12:05pm | HDV: reflex testing, status of anti-HDV & RNA testing in NA |
12:05pm – 12:20pm | PANEL DISCUSSION |
Session 34: Vaccination – an important cornerstone in Prevention | |
12:25pm – 12:40pm | Suggest Catch-up HepB Vaccination Strategies for all or at risk adults |
12:40pm – 12:55pm | HCV Vaccine trials in NA status report |
LUNCH 1pm – 2pm | Session 3: Prevention Beyond Vaccination |
2:05pm – 2:20pm | Next Steps in Elimination of MTCT of HBV and HCV in North America |
2:20pm – 2:35pm | Liver cancer in VH in North America – surveillance challenges and solutions |
2:35pm – 3:05pm | PANEL DISCUSSION: Includes session 3 speakers also |
Session 5: Health equity: Delivering VH care in persons using drugs | |
3:10pm – 3:25pm | Prevention of HCV among PWID in Mexico |
3:25pm – 3:40pm | PWIDs – novel programs in U.S. |
3.40pm – 3:55pm | Supervised injection sites and SSPs in Canada |
3:55pm – 4:15pm | PANEL DISCUSSION: Includes patient representation (WHA) |
4:15pm – 4:30pm | Wrap-up and Next Steps: Blueprint/Roadmap strategy |
